Potential effectiveness of Vitrakvi (Larotrectinib) for treating types of solid tumors carrying NTRK genes and the impact of TRKC mutations
Vitrakvi is a cancer treatment that targets solid tumors with NTRK gene fusion. NTRKs are rare genetic effects that can arise in tumors from several organs, including the lungs, thyroid glands, and intestines. This study sought to identify the position at which Vitrakvi binds to tropomyosin recepto...
Saved in:
| Main Author: | Ali Adel Dawood |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Universidad Politécnica Salesiana
2025-04-01
|
| Series: | La Granja: Revista de Ciencias de la Vida |
| Subjects: | |
| Online Access: | https://lagranja.ups.edu.ec/index.php/granja/article/view/9706 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Three locally invasive infantile fibrosarcoma cases treated with larotrectinib
by: Hikmet Gülşah Tanyıldız, et al.
Published: (2025-02-01) -
NTRK fusion promotes tumor migration and invasion through epithelial–mesenchymal transition and closely interacts with ECM1 and NOVA1
by: Siqing Zeng, et al.
Published: (2024-12-01) -
Sructural rearrangements of NTRK genes: characteristics, methods of detection and targeted therapy for cancer
by: A. A. Kechin, et al.
Published: (2022-01-01) -
Utility of a commercial antibody against NTRK1 for western blotting and potential application to immunohistochemistry in adult mouse brain
by: Kazuo Nakajima, et al.
Published: (2025-02-01) -
Larotrectinib in NTRK3 fusion–positive metastatic secretory carcinoma of the breast: A case study
by: Martin Dietrich, et al.
Published: (2025-03-01)